Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 289.40
+3.20 (1.12%)
Jul 9, 2025, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 9.12 billion as of July 9, 2025. Its market cap has decreased by -32.62% in one year.
Market Cap
9.12B
Enterprise Value
8.83B
Revenue
854.98M
Ranking
n/a
PE Ratio
66.86
Stock Price
289.40
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 9.12B, an increase of 2,352.55%. That is a compound annual growth rate of 28.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 98.92B |
| Sectra AB | 67.75B |
| Getinge AB | 51.75B |
| Asker Healthcare Group AB | 41.10B |
| Camurus AB | 40.11B |
| Medicover AB | 39.56B |
| AddLife AB | 22.62B |
| Vimian Group AB | 21.99B |